U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs
Posted inCenters for Disease Control and Prevention Compensation for Damages (Law) Decisions and Verdicts Drugs (Pharmaceuticals) Gilead Sciences Inc Health and Human Services Department Inventions and Patents Suits and Litigation (Civil)

U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.
Juul Reaches $462 Million Settlement With New York, California and Other States
Posted inAdvertising and Marketing California Centers for Disease Control and Prevention Colorado E-Cigarettes Food and Drug Administration Illinois Juul Labs Inc Massachusetts New York State Smoking and Tobacco Suits and Litigation (Civil) Teenagers and Adolescence

Juul Reaches $462 Million Settlement With New York, California and Other States

The case ends major litigation over claims of marketing e-cigarettes to adolescents, resolving thousands of lawsuits and amounting to billions of dollars in payouts to states, cities and people.
What to Know About the Recent Eye Drop Recalls
Posted inCenters for Disease Control and Prevention Containers and Packaging Drug Resistance (Microbial) Drugs (Pharmaceuticals) Eyes and Eyesight Factories and Manufacturing Food and Drug Administration Infections Recalls and Bans of Products

What to Know About the Recent Eye Drop Recalls

Global Pharma recalled eye drops in February after they were tied to a drug-resistant bacteria strain linked to at least one death. Two more companies have since recalled eye drops.